Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.23M | -1.15M | -1.31M | -1.32M | 2.00K |
| Total Depreciation and Amortization | 79.00K | 111.00K | 105.00K | 103.00K | 102.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 113.00K | -247.00K | 40.00K | 105.00K | 178.00K |
| Change in Net Operating Assets | 238.00K | 369.00K | -83.00K | 121.00K | -550.00K |
| Cash from Operations | -802.00K | -912.00K | -1.25M | -991.00K | -268.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 18.00K | -19.00K | -- | -- |
| Cash from Investing | -- | 18.00K | -19.00K | -- | -- |
| Total Debt Issued | -- | 500.00K | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.23M | 379.00K | 63.00K | 493.00K | 939.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -8.00K | -2.00K | -11.00K | -19.00K |
| Cash from Financing | 2.23M | 871.00K | 61.00K | 482.00K | 920.00K |
| Foreign Exchange rate Adjustments | -4.00K | -5.00K | 1.00K | -1.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.43M | -28.00K | -1.21M | -510.00K | 654.00K |